Active Ingredient(s): Zidovudine, ZDV
FDA Approved: * March 19, 1987
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Retrovir Overview

Zidovudine (ZDV), also known as azidothymidine (AZT), is an antiretroviral medication used to prevent and treat HIV/AIDS.[5] It is generally recommended for use with other antiretrovirals.[5] It may be used to prevent mother-to-child spread during birth or after a needlestick injury or other potential exposure.[5] It is sold both by itself and together as lamivudine/zidovudine and abacavir/lamivudine/zidovudine.[5] It can be used...

Read more Retrovir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Retrovir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Zidovudine, ZDV
  • Capsule: 100mg
  • Injection: 10mg/ml
  • Solution: 50mg/5ml
  • Syrup: 10mg/ml, 50mg/5ml
  • Tablet: 200mg, 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Retrovir: (5 results)

Sorted by National Drug Code
  • 49702-211 Retrovir 100 mg Oral Capsule by Viiv Healthcare Company
  • 49702-212 Retrovir 10 mg/ml Oral Syrup by Viiv Healthcare Company
  • 49702-213 Retrovir 10 mg/ml Intravenous Injection, Solution by Viiv Healthcare Company
  • 49702-214 Retrovir 300 mg Oral Tablet by Viiv Healthcare Company
  • 63379-026 Retrovir 10 mg/ml Intravenous Injection, Solution by Glaxo Operations Uk Ltd

Other drugs which contain Zidovudine, ZDV or a similar ingredient: (6 results)